Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick van Sleen

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|February 27, 2019
Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritisYannick van Sleen, Maria Sandovici, Wayel H Abdulahad, et al.
Frontiers in Immunology|August 21, 2023
Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumaticaRosanne D Reitsema, Bernd-Cornèl Hesselink, Wayel H Abdulahad, et al.
Frontiers in Immunology|September 12, 2019
Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia RheumaticaYannick van Sleen, Jacoba C Graver, Wayel H Abdulahad, et al.
Scientific Reports|July 28, 2017
Involvement of Monocyte Subsets in the Immunopathology of Giant Cell ArteritisYannick van Sleen, Qi Wang, Kornelis S M van der Geest, et al.
Journal of Clinical Medicine|November 13, 2021
Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and TreatmentIdil Esen, William F Jiemy, Yannick van Sleen, et al.
Frontiers in Immunology|July 3, 2023
Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patientsMarieke van Nieuwland, Idil Esen, Rosanne D Reitsema, et al.
Journal of Virology|May 12, 2026
Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adultsLisa van Pul, Sietske Karla Rosendahl Huber, Ronald Jacobi, et al.
Rheumatology (Oxford, England)|March 14, 2025
Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritisShuang Xu, William Jiemy, Yannick van Sleen, et al.
RMD Open|January 11, 2023
Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohortIdil Esen, Suzanne Arends, Berit Dalsgaard Nielsen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2021
A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 AxisYannick van Sleen, William F Jiemy, Sarah Pringle, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|February 27, 2019
Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritisYannick van Sleen, Maria Sandovici, Wayel H Abdulahad, et al.
Frontiers in Immunology|August 21, 2023
Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumaticaRosanne D Reitsema, Bernd-Cornèl Hesselink, Wayel H Abdulahad, et al.
Frontiers in Immunology|September 12, 2019
Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia RheumaticaYannick van Sleen, Jacoba C Graver, Wayel H Abdulahad, et al.
Scientific Reports|July 28, 2017
Involvement of Monocyte Subsets in the Immunopathology of Giant Cell ArteritisYannick van Sleen, Qi Wang, Kornelis S M van der Geest, et al.
Journal of Clinical Medicine|November 13, 2021
Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and TreatmentIdil Esen, William F Jiemy, Yannick van Sleen, et al.
Frontiers in Immunology|July 3, 2023
Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patientsMarieke van Nieuwland, Idil Esen, Rosanne D Reitsema, et al.
Journal of Virology|May 12, 2026
Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adultsLisa van Pul, Sietske Karla Rosendahl Huber, Ronald Jacobi, et al.
Rheumatology (Oxford, England)|March 14, 2025
Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritisShuang Xu, William Jiemy, Yannick van Sleen, et al.
RMD Open|January 11, 2023
Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohortIdil Esen, Suzanne Arends, Berit Dalsgaard Nielsen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2021
A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 AxisYannick van Sleen, William F Jiemy, Sarah Pringle, et al.
Pageof 5